According to data from think tank organization Astute Analytica, the smart electronic cigarette market in the United States (both with and without displays) was valued at $364.7 million in 2021 and is expected to reach $2.664.9 billion by the end of 2027.
During the forecast period of 2022-2027, the compound annual growth rate of this market is projected to be 39.3%. In terms of quantity, the US smart e-cigarette market is expected to have a compound annual growth rate of 34.6% between 2022-2027.
According to a study by Astute Analytica, electronic cigarettes without screens currently dominate the smart electronic cigarette market in the United States with a 2021 market share of 86.2%. It is projected to grow at a compound annual growth rate of 34.3% during the forecast period.
However, electronic cigarettes with screens are expected to grow at a compound annual growth rate of 56%. Smart electronic cigarettes with screens display battery status and ingredient levels, which helps consumers predict usage time and thus accelerate overall growth in the near future.
Reference(s):
The smart e-cigarette market in the United States is projected to grow significantly by 2027. The industry dynamic is divided into two types: those with screens and those without screens, as well as online and offline distribution channels. This report provides a market size estimate and offers insights into opportunities and forecasts for the industry.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
